Sarepta Therapeutics (SRPT) Stock: Continues Skyward on FDA Approval

By |September 20th, 2016|

Sarepta Therapeutics Inc (NASDAQ: SRPT)

Sarepta Therapeutics saw massive gains of over 80% in yesterday’s trading session. Today, those gains are continuing, and for good reason. Yesterday, the company announced that it’s flagship candidate has been approved by the FDA. Today, we’ll talk about the news, what we’re seeing from the stock today, and what […]